Core Viewpoint - Ningbo Tianyi Medical Instrument Co., Ltd. has announced the establishment of a special account for raised funds and signed a five-party supervision agreement for the management of these funds, shifting the focus from a previously planned project to a new project in Thailand [1][2]. Fundraising Basic Information - The company raised a total of 14736800 shares at an issuance price of RMB 52.37 per share, resulting in total fundraising of approximately RMB 772.5 million. After deducting related expenses of RMB 18.04 million, the net amount raised is RMB 694.56 million [1][2]. Changes in Fund Usage - The company has decided to terminate the original fundraising project for the "Comprehensive R&D Center Construction Project" and redirect all remaining funds to the new "Thailand Production Base Construction Project" [1][2]. Establishment of Special Fund Account - A special account for the raised funds has been established at the Industrial and Commercial Bank of China (Thailand) with the account number 5100303754, specifically for the Thailand production base project [2][3]. Five-Party Supervision Agreement - The five-party supervision agreement includes the company, its Singapore subsidiary, its Thai subsidiary, the Industrial and Commercial Bank of China (Thailand), and the sponsor, Guotai Junan Securities. This agreement aims to regulate the management of the raised funds and protect the rights of small investors [5][6]. Fund Transfer Process - The process for transferring the remaining funds involves several steps, including returning funds from the subsidiary to the company and then transferring them to newly established accounts for both RMB and USD at the Shanghai Pudong Development Bank [2][4]. Completion of Fund Management Steps - The company has completed the necessary steps for fund management, including the reduction of capital for its subsidiary and the establishment of both RMB and USD special accounts at the Shanghai Pudong Development Bank [3][4].